Position in TENX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,787,439
+$23,456,482 QoQ
Shares Held
1,675,262
+282.7% QoQ
Ownership
4.48%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TENX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
8,493,321 | $1,127,318,496 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
4,148,428 | $394,805,892 | |
| 3 | ERAS |
Erasca, Inc.
|
17,891,812 | $327,777,995 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,985,448 | $265,048,073 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,180,000 | $115,026,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
10,346,926 | $101,606,813 | |
| 7 | DMRA |
Damora Therapeutics, Inc.
|
3,603,595 | $93,729,505 | |
| 8 | SVRA |
Savara Inc
|
14,745,943 | $90,835,008 |
All Filings in TENX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,787,439 | 1,675,262 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $3,330,957 | 437,708 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $567,728 | 98,564 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,364,581 | 208,333 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,289,581 | 208,333 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $720,832 | 208,333 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||